SPEAKER: Rebecca (Becky)Richards, MD - Assistant Professor, Hem/Onc & Bone Marrow Transplant. Department of Pediatrics, University of Wisconsin-Madison & Michael Wilhelm, MD, Associate Professor, Critical Care, Department of Pediatrics, University of Wisconsin -Madison
TITLE: Department of Pediatrics: Summer Research Potpourri
As a result of participating in this educational activity, learners as members of the healthcare team will be able to:
Richards Learning Objectives:
1. Summarize the indications for clinical use of CAR T-cell therapy in pediatric patients
2. Identify two barriers to successful implementation of CAR T-cell therapy for treatment of AML
3. Describe one strategy to minimize on-target, off-tumor toxicity of CAR T cells
Wilhelm’s Learning Objectives:
- Evaluate the key components of a quality improvement program
- Explain mechanisms to engage frontline providers in ongoing improvement
- Apply statistical process control charts in improvement efforts
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™